LU75901A1 - - Google Patents

Info

Publication number
LU75901A1
LU75901A1 LU75901A LU75901A LU75901A1 LU 75901 A1 LU75901 A1 LU 75901A1 LU 75901 A LU75901 A LU 75901A LU 75901 A LU75901 A LU 75901A LU 75901 A1 LU75901 A1 LU 75901A1
Authority
LU
Luxembourg
Application number
LU75901A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/618,176 external-priority patent/US4004005A/en
Application filed filed Critical
Publication of LU75901A1 publication Critical patent/LU75901A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU75901A 1975-09-30 1976-09-28 LU75901A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/618,176 US4004005A (en) 1975-09-30 1975-09-30 Steroidal erythropoietic agents and therapeutic compositions and methods
US05/693,249 US4049805A (en) 1975-09-30 1976-06-04 Steroidal erythropoietic agents and therapeutic compositions and methods

Publications (1)

Publication Number Publication Date
LU75901A1 true LU75901A1 (fr) 1977-05-11

Family

ID=27088168

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75901A LU75901A1 (fr) 1975-09-30 1976-09-28

Country Status (10)

Country Link
US (1) US4049805A (fr)
JP (1) JPS5262263A (fr)
CH (1) CH625253A5 (fr)
DE (1) DE2643936A1 (fr)
DK (1) DK145859C (fr)
FR (1) FR2326198A1 (fr)
GB (1) GB1565229A (fr)
IE (1) IE43859B1 (fr)
LU (1) LU75901A1 (fr)
NL (1) NL7610812A (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US20050042679A1 (en) * 1999-04-15 2005-02-24 Monash University Diagnostic indicator of thymic function
US20050020524A1 (en) * 1999-04-15 2005-01-27 Monash University Hematopoietic stem cell gene therapy
US20040258672A1 (en) * 1999-04-15 2004-12-23 Monash University Graft acceptance through manipulation of thymic regeneration
US20040265285A1 (en) * 1999-04-15 2004-12-30 Monash University Normalization of defective T cell responsiveness through manipulation of thymic regeneration
AUPR074500A0 (en) * 2000-10-13 2000-11-09 Monash University Treatment of t cell disorders
US20040241842A1 (en) * 1999-04-15 2004-12-02 Monash University Stimulation of thymus for vaccination development
US20040259803A1 (en) * 1999-04-15 2004-12-23 Monash University Disease prevention by reactivation of the thymus
US20060088512A1 (en) * 2001-10-15 2006-04-27 Monash University Treatment of T cell disorders
AP2003002796A0 (en) * 2000-10-13 2003-06-30 Richard Boyd Disease prevention by reactivation of the thymus
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20080279812A1 (en) * 2003-12-05 2008-11-13 Norwood Immunology, Ltd. Disease Prevention and Vaccination Prior to Thymic Reactivation
CA2789262C (fr) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Systeme pharma-informatique
EP1945240B1 (fr) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions de proteines rap specifiques des proteines contenant du cr, et leurs utilisations
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Also Published As

Publication number Publication date
US4049805A (en) 1977-09-20
NL7610812A (nl) 1977-04-01
FR2326198B1 (fr) 1980-10-10
IE43859B1 (en) 1981-06-17
GB1565229A (en) 1980-04-16
DK437976A (da) 1977-03-31
DK145859C (da) 1983-10-03
JPS5262263A (en) 1977-05-23
DK145859B (da) 1983-03-21
IE43859L (en) 1977-03-30
DE2643936A1 (de) 1977-03-31
FR2326198A1 (fr) 1977-04-29
CH625253A5 (fr) 1981-09-15

Similar Documents

Publication Publication Date Title
FR2308320B1 (fr)
FR2326198B1 (fr)
FR2299223B1 (fr)
FR2327446B1 (fr)
JPS5253552U (fr)
JPS51143286U (fr)
JPS5224327U (fr)
JPS51124079U (fr)
JPS5320797Y2 (fr)
FR2311714B1 (fr)
JPS5346346Y2 (fr)
JPS5523040Y2 (fr)
AU8233875A (fr)
JPS5276941U (fr)
JPS5283183U (fr)
JPS5285381U (fr)
JPS5138095U (fr)
BG22692A1 (fr)
CH605255A5 (fr)
CH603867A5 (fr)
BG22607A1 (fr)
BG22103A1 (fr)
CH613048A5 (fr)
CH612187A5 (fr)
CH610603A5 (fr)